
Eli Lilly launches anti-obesity and diabetes drug Mounjaro in India, priced competitively at Rs 14,000-17,500, a fraction of its US…
The future of medicine is being shaped by a confluence of factors at play. If there are worries galore around…
India has a strong pharma network, with more than 10,000 manufacturing facilities, over 3,000 pharma companies.
India currently exports about $8.7 billion worth of formulations (generic drugs) and $1 billion of API (active pharmaceutical ingredients) annually…
All eyes are now on the appetite of the suppliers (the drug makers from India) and buyers (the major drug…
Pharma stocks are down, but is this a golden buying opportunity? With India’s booming sector and low P/E stocks in…
Kotak Institutional Equities analysed the base and worst case scenarios in the event of the tariff hike by the US…
Dr Hamied, as the scientist-entrepreneur is better known, is not particularly concerned about the impact of tariffs on imported medicines…
FIIs hold record index shorts, hinting at potential market fall. Oil & Gas poised for gains; watch Reliance, Adani, ONGC.…
IPA primarily represents companies specializing in producing generic drugs, which are lower-cost versions of branded medications.
While foreign investors have been reducing their exposure to Indian pharma, some leading domestic institutional investors (DIIs) are doing exactly…
Watch for significant moves in Nifty and Bank Nifty as market braces for new trading range. Explore metal and pharma…
The Union Budget 2025 has waived import duty on 36 life-saving drugs and reduced it for six others. While this…
Pharma Sector Multibagger Opportunity – Explore how India could win big in the CDMO space with China-Plus-One strategy, growing investments,…
According to the expoters, section 43B(h) of the Income Tax Act, which came into effect in April 2024, has severely…
Experts argue that despite the current developments, the growth of Indian CDMOs and CROs will pick up pace due to…
The Centre has plans to build at least one major hospital in each of India’s 761 districts to improve healthcare…
India’s attractiveness as a GCC destination has grown exponentially with over 1700+ GCCs today, employing more than 1.5 million professionals,…